• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Balchem Corporation filed SEC Form 8-K: Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

    9/20/24 4:15:19 PM ET
    $BCPC
    Major Chemicals
    Industrials
    Get the next $BCPC alert in real time by email
    false12-31000000932600000093262024-09-182024-09-18

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    FORM 8-K

    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): September 18, 2024

    Balchem Corporation
    (Exact name of registrant as specified in its charter)

    Maryland
    1-13648
    13-2578432
    (State or other jurisdiction of incorporation)
    (Commission File Number)
    (IRS Employer Identification No.)

    5 Paragon Drive, Montvale, NJ 07645
    (Address of principal executive offices) (Zip Code)

    Registrant’s telephone number, including area code: (845) 326-5600

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

    ☐
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

    ☐
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

    ☐
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


    ☐
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:
    Title of each class
    Trading
    Symbol(s)
    Name of each exchange on which registered
    Common Stock, par value $.06-2/3 per share
    BCPC
    The Nasdaq Stock Market LLC

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company        ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.          ☐



    Item 5.02
    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

    In order to rebalance the number of directors serving in each class of the Board of Directors (the “Board”) of Balchem Corporation, a Maryland corporation (the “Company”), so that each of the three classes shall consist, as nearly as possible, of one-third of the total number of directors, in accordance with Article III, Section 2 of the Company’s by-laws, effective as of September 20, 2024, (1) Daniel Knutson resigned from his position as Class 2 director and was immediately elected by the Board as Class 3 director; (2) Joyce Lee resigned from her position as Class 2 director and was immediately elected by the Board as Class 3 director; (3) Monica Vicente resigned as Class 2 director and was immediately elected to the Board as Class 1 director; and (4) Kathleen Fish resigned as Class 1 director and was immediately elected to the Board as Class 2 director.

    The above resignations and re-elections were effected solely for the purpose of reclassification, and for all other purposes, the respective directors’ service on the Board is deemed to have continued uninterrupted.

    The Board now consists of three Class 1 directors whose term will expire at the annual meeting of shareholders to be held in 2025, two Class 2 directors whose term will expire at the annual meeting of shareholders to be held in 2027, and three Class 3 directors whose term will expire at the annual meeting of shareholders to be held in 2026.

    Item 5.03
    Amendments to Articles of Incorporation or Bylaws.

    On September 18, 2024, the Board adopted a resolution providing that the Company elected to be subject to 3-804(c) of the Maryland General Corporation Law, which provides that all vacancies on the Board may be filled only by the affirmative vote of a majority of the directors remaining in office, even if the remaining directors do not constitute a quorum, and any director elected to fill a vacancy shall serve for the remainder of the full term of the class of directors in which the vacancy occurred and until a successor is elected and qualifies. The Company filed Articles Supplementary reflecting such election with the State Department of Assessments and Taxation of the State of Maryland on September 19, 2024. The summary above is qualified in its entirety by reference to the full text of the Articles Supplementary, which is filed as Exhibit 3.1 to this Current Report on Form 8-K, and is incorporated herein by reference.

    Item 9.01
    Financial Statements and Exhibits.

    (d)  Exhibits

    Exhibit Number
    Description
    3.1
    Articles Supplementary
    104 Cover Page Interactive Data File (embedded within the Inline XBRL document)


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     
    BALCHEM CORPORATION
     
    (Registrant)
       
     
    By:
    /s/ Hatsuki Miyata
     
     
    Hatsuki Miyata
     
    Executive Vice President, General Counsel and Secretary
       
    Date: September 20, 2024
     



    Get the next $BCPC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BCPC

    DatePrice TargetRatingAnalyst
    12/5/2025$162.00Neutral
    Rothschild & Co Redburn
    3/8/2022$170.00 → $155.00Buy
    HC Wainwright & Co.
    2/22/2022$175.00Neutral → Buy
    Sidoti
    1/10/2022$160.00 → $170.00Buy
    HC Wainwright & Co.
    11/29/2021$175.00Buy → Neutral
    Sidoti
    8/2/2021$140.00 → $145.00Overweight → Equal-Weight
    Stephens & Co.
    8/2/2021$145.00 → $160.00Buy
    HC Wainwright & Co.
    More analyst ratings

    $BCPC
    SEC Filings

    View All

    SEC Form 10-K filed by Balchem Corporation

    10-K - BALCHEM CORP (0000009326) (Filer)

    2/20/26 4:26:06 PM ET
    $BCPC
    Major Chemicals
    Industrials

    Balchem Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - BALCHEM CORP (0000009326) (Filer)

    2/20/26 7:38:57 AM ET
    $BCPC
    Major Chemicals
    Industrials

    Balchem Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - BALCHEM CORP (0000009326) (Filer)

    2/19/26 4:16:14 PM ET
    $BCPC
    Major Chemicals
    Industrials

    $BCPC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Gilson Erin Leigh

    3 - BALCHEM CORP (0000009326) (Issuer)

    4/7/26 4:56:17 PM ET
    $BCPC
    Major Chemicals
    Industrials

    SVP and GM, Specialty Products Van Gunsteren Job Leonard was granted 1,775 shares and covered exercise/tax liability with 814 shares, increasing direct ownership by 10% to 10,149 units (SEC Form 4)

    4 - BALCHEM CORP (0000009326) (Issuer)

    2/13/26 7:11:01 PM ET
    $BCPC
    Major Chemicals
    Industrials

    SVP Chief Supply Chain Officer Reid Martin Luther was granted 3,299 shares and covered exercise/tax liability with 1,201 shares, increasing direct ownership by 30% to 9,073 units (SEC Form 4)

    4 - BALCHEM CORP (0000009326) (Issuer)

    2/13/26 7:05:59 PM ET
    $BCPC
    Major Chemicals
    Industrials

    $BCPC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Balchem Corporation Announces Quarterly Conference Call for First Quarter 2026 Financial Results on April 30, 2026

    MONTVALE, N.J., April 16, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC) today announced that a conference call will be held on Thursday, April 30, 2026, at 11:00 AM Eastern Time (ET) to review first quarter results. Ted Harris, Chairman of the Board, President and CEO, and Martin Bengtsson, CFO, will host the call. First quarter results will be published prior to the market opening on Thursday, April 30, 2026. The press release, and its accompanying financial exhibits, will also be available on the Company website, www.balchem.com, prior to the conference call. Institutional investors, analysts and other members of the financial community are invited to join the live call by

    4/16/26 7:00:00 AM ET
    $BCPC
    Major Chemicals
    Industrials

    Balchem Launches Metalosate® T.E.A.M.™ Plant Tissue Analysis Digital Platform to Deliver Research-Driven Nutrient Recommendations for Specialty Crops

    MONTVALE, N.J., March 09, 2026 (GLOBE NEWSWIRE) -- Balchem Plant Nutrition, a global leader in chelated mineral plant nutrition and the maker of Metalosate® micronutrients, today announced the launch of its Metalosate® T.E.A.M.™ plant tissue analysis digital platform. The platform helps advisors optimize nutrient balance to enhance yield potential and crop quality, while reducing unnecessary input cost in specialty crops. Built as a free service for pest control advisors and agronomists, T.E.A.M. translates plant tissue analysis results into targeted nutrition recommendations that growers can act on with confidence. T.E.A.M., which stands for Technical Evaluation of Albion Minerals, is a

    3/9/26 8:00:00 AM ET
    $BCPC
    Major Chemicals
    Industrials

    Balchem Corporation to Participate in the BNP Paribas Exane Consumer Ingredients & Chemicals Conference on March 11, 2026

    MONTVALE, N.J., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in the BNP Paribas Exane Consumer Ingredients & Chemicals Conference on March 11, 2026. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer and Allison Baurichter, Senior Director Investor Relations will participate in the conference. About Balchem Corporation Balchem Corporation develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-of-the

    2/25/26 7:00:00 AM ET
    $BCPC
    Major Chemicals
    Industrials

    $BCPC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Rothschild & Co Redburn initiated coverage on Balchem with a new price target

    Rothschild & Co Redburn initiated coverage of Balchem with a rating of Neutral and set a new price target of $162.00

    12/5/25 8:39:34 AM ET
    $BCPC
    Major Chemicals
    Industrials

    HC Wainwright & Co. reiterated coverage on Balchem with a new price target

    HC Wainwright & Co. reiterated coverage of Balchem with a rating of Buy and set a new price target of $155.00 from $170.00 previously

    3/8/22 6:19:56 AM ET
    $BCPC
    Major Chemicals
    Industrials

    Balchem upgraded by Sidoti with a new price target

    Sidoti upgraded Balchem from Neutral to Buy and set a new price target of $175.00

    2/22/22 8:56:13 AM ET
    $BCPC
    Major Chemicals
    Industrials

    $BCPC
    Financials

    Live finance-specific insights

    View All

    Balchem Corporation Announces Quarterly Conference Call for First Quarter 2026 Financial Results on April 30, 2026

    MONTVALE, N.J., April 16, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC) today announced that a conference call will be held on Thursday, April 30, 2026, at 11:00 AM Eastern Time (ET) to review first quarter results. Ted Harris, Chairman of the Board, President and CEO, and Martin Bengtsson, CFO, will host the call. First quarter results will be published prior to the market opening on Thursday, April 30, 2026. The press release, and its accompanying financial exhibits, will also be available on the Company website, www.balchem.com, prior to the conference call. Institutional investors, analysts and other members of the financial community are invited to join the live call by

    4/16/26 7:00:00 AM ET
    $BCPC
    Major Chemicals
    Industrials

    Balchem Corporation Reports Fourth Quarter and Full Year 2025 Financial Results

    MONTVALE, N.J., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC) reported today financial results for its 2025 fiscal fourth quarter and full year ended December 31, 2025. For the quarter, the Company reported net sales of $263.6 million, net earnings of $39.2 million, adjusted EBITDA(a) of $67.9 million, and free cash flow(a) of $51.2 million. For the full year 2025, the Company reported net sales of $1.037 billion, net earnings of $154.8 million, adjusted EBITDA of $274.9 million, and free cash flow of $173.6 million. Ted Harris, Chairman, President, and CEO of Balchem said, "In the fourth quarter, Balchem's strong growth trajectory continued. We delivered record fo

    2/20/26 7:12:32 AM ET
    $BCPC
    Major Chemicals
    Industrials

    Balchem Corporation Announces Quarterly Conference Call for Fourth Quarter and Full Year 2025 Financial Results on February 20, 2026

    MONTVALE, N.J., Feb. 06, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC) today announced that a conference call will be held on Friday, February 20, 2026, at 11:00 AM Eastern Time (ET) to review fourth quarter and full year 2025 results. Ted Harris, Chairman of the Board, President and CEO, and Martin Bengtsson, CFO, will host the call. Fourth quarter and full year 2025 results will be published prior to the market opening on Friday, February 20, 2026. The press release, and its accompanying financial exhibits, will also be available on the Company website, www.balchem.com, prior to the conference call. Institutional investors, analysts and other members of the financial commu

    2/6/26 7:00:00 AM ET
    $BCPC
    Major Chemicals
    Industrials

    $BCPC
    Leadership Updates

    Live Leadership Updates

    View All

    AzurRx BioPharma Announces Appointment of Terry Coelho to its Board of Directors

    BOCA RATON, Fla., Aug. 16, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. ("AzurRx" or the "Company") (NASDAQ:AZRX), a company specializing in the development of targeted non-systemic, therapies for gastrointestinal (GI) diseases, today announced the appointment of Terry Coelho to its Board of Directors effective immediately. The appointment increases the size of AzurRx's Board to seven members. Ms. Coelho currently serves as the Executive Vice President and Chief Financial Officer at BioDelivery Sciences International, Inc. (NASDAQ:BDSI), a commercial-stage specialty pharmaceutical company. During her more than 30-year career, Ms. Coelho has held numerous senior level financial an

    8/16/21 8:00:00 AM ET
    $AZRX
    $BCPC
    $BDSI
    Major Pharmaceuticals
    Health Care
    Major Chemicals
    Industrials

    $BCPC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Balchem Corporation

    SC 13G/A - BALCHEM CORP (0000009326) (Subject)

    11/13/24 6:56:07 PM ET
    $BCPC
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by Balchem Corporation (Amendment)

    SC 13G/A - BALCHEM CORP (0000009326) (Subject)

    2/13/24 4:59:02 PM ET
    $BCPC
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by Balchem Corporation (Amendment)

    SC 13G/A - BALCHEM CORP (0000009326) (Subject)

    2/9/24 11:29:17 AM ET
    $BCPC
    Major Chemicals
    Industrials